Lawmakers Urge FDA To Rethink Drug Labeling

Law360, New York (January 24, 2008, 12:00 AM EST) -- A group of lawmakers has asked the U.S. Food and Drug Administration to reconsider a proposed rule regarding drug labeling, saying it was designed to shield pharmaceutical and device companies from liability for injuries sustained by American consumers as a result of unsafe products.

Eight congressional Democrats led by Rep. Henry A. Waxman, D-Calif., and Sen. Edward M. Kennedy, D-Mass., said in a letter sent Wednesday to FDA Commissioner Andrew von Eschenbach that they are concerned that the proposal is intended to protect companies from being...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.